MyFinsight
Home
Blog
About
something is missing
$81,658K
Other segment items
-$62,506K
(-179.96%↓ Y/Y)
Payroll expense
-$41,493K
(-142.62%↓ Y/Y)
Depreciation and
amortization expense
-$13,695K
(-148.52%↓ Y/Y)
Consulting and outside
services expense
-$6,377K
(-135.73%↓ Y/Y)
Materials and supplies
-$6,103K
(-128.13%↓ Y/Y)
Interest expense
-$5,639K
(-144.87%↓ Y/Y)
Stock-based compensation
expense
-$4,708K
(-131.86%↓ Y/Y)
Advertising and promotional
expense
-$3,229K
(-146.29%↓ Y/Y)
Net income
$30,348K
(-46.11%↓ Y/Y)
Depreciation of property,
plant, and equipment
$8,042K
(-48.83%↓ Y/Y)
Income tax refunds,
deposits, and payable, net
-$7,105K
(-183.91%↓ Y/Y)
Share-based compensation
expense
$7,090K
(-52.01%↓ Y/Y)
Maturity of investments
$64,317K
(25.32%↑ Y/Y)
Canceled cashflow
$195,060K
Amortization of intangible
assets
$6,269K
(-49.88%↓ Y/Y)
Accounts receivable, net
-$2,979K
(28.94%↑ Y/Y)
Operating lease
right-of-use asset...
$2,149K
(-33.28%↓ Y/Y)
Accounts payable and
accrued liabilities
$1,960K
(-84.62%↓ Y/Y)
Amortization of discounts,
premiums, and debt...
$875K
(-45.45%↓ Y/Y)
Loss on disposal of
assets
-$9K
(71.88%↑ Y/Y)
Net cash provided by
operating activities
$51,324K
(-27.37%↓ Y/Y)
Net cash provided by
investing activities
$44,870K
(355.26%↑ Y/Y)
Canceled cashflow
$15,502K
Effect of exchange rate
changes on cash
$16K
(-93.85%↓ Y/Y)
Canceled cashflow
$19,447K
Net revenues
-$181,708K
(-152.68%↓ Y/Y)
Income tax provision
$8,196K
(-40.96%↓ Y/Y)
Clinical trials expense
$3,587K
(215.48%↑ Y/Y)
Interest income
-$1,569K
(60.87%↑ Y/Y)
Net increase in
cash, cash...
$52,675K
(46.00%↑ Y/Y)
Canceled cashflow
$43,535K
Inventories
$9,879K
(-72.51%↓ Y/Y)
Prepaid expenses and
other assets
$2,543K
(-53.06%↓ Y/Y)
Operating lease
liabilities
-$2,201K
(6.82%↑ Y/Y)
(gain) loss on interest
rate swaps and...
$879K
(150.63%↑ Y/Y)
Purchase of investments
$8,995K
(-42.41%↓ Y/Y)
Purchases and
construction of property,...
$8,591K
(-59.59%↓ Y/Y)
Deposits and other assets
$1,861K
(-20.30%↓ Y/Y)
Proceeds from equity
plans, net of...
$831K
(68.22%↑ Y/Y)
Net cash used in
financing activities
-$43,535K
(2.62%↑ Y/Y)
Canceled cashflow
$831K
Purchase of treasury
stock
$45,213K
(-9.97%↓ Y/Y)
Back
Back
Cash Flow
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)
source: myfinsight.com